A Safety and Effectiveness Study of JUVÉDERM VOLBELLA® XC Injectable Gel for Lip and Perioral Enhancement

NACompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

November 1, 2013

Primary Completion Date

August 4, 2014

Study Completion Date

May 29, 2015

Conditions
Subjects Desiring Lip Augmentation
Interventions
DEVICE

JUVEDERM VOLBELLA® XC

Up to 1.5 mL per lip (upper and lower) at each treatment (initial, touch-up, and repeat treatment). Additional product may be injected into the perioral area, as long as the total injection volume does not exceed 6.0 mL. Up to 6.0 mL allowed for repeat treatment.

DEVICE

Restylane-L®

Up to 1.5 mL per lip (upper and lower) at each treatment (initial, touch-up, and repeat treatment). Additional product may be injected into the perioral area, as long as the total injection volume does not exceed 6.0 mL.. Up to 6.0 mL allowed for repeat treatment.

Trial Locations (1)

Unknown

New Orleans

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY